AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

NKGen Biotech, Inc. Common Stock

$0.01 -$0.04 (-78.00%)
OTC · 29 Oct 2026 14:12 UTC
Previous Close
$0.01
Day Range
$0.01 - $0.01
Year Range
$0.00$0.77
Market Cap
1.44M
AVG Volume
4.34K
Trailing/Forward PE
-0.01/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD) · A
0200K400K600K800K2021202220232024
NKGN Revenue (USD) by year
PeriodRevenue (USD)
2024652K
20230
20223K
20210
Net Income (USD) · A
-100M-75M-50M-25M02021202220232024
NKGN Net Income (USD) by year
PeriodNet Income (USD)
2024-44.29M
2023-82.95M
2022-6.96M
2021-990.64K
Operating Income (USD) · A
-30M-20M-10M02021202220232024
NKGN Operating Income (USD) by year
PeriodOperating Income (USD)
2024-26.97M
2023-29.74M
2022-13.95M
2021-2.51M
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: NKGN

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one.

NKGen Biotech, Inc. Common Stock
NKGN
Stockpicker

Video analysis: NKGN

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: NKGN

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.